Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BPMC | AMGN | VRTX | REGN | BMY |
| Company | Blueprint Medicines Corp | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 107.93 | 310.88 | 402.77 | 958.00 | 44.16 |
| High | 108.51 | 312.73 | 407.59 | 962.10 | 44.62 |
| Low | 105.48 | 297.52 | 401.16 | 950.27 | 43.91 |
| Last | 106.67 | 299.99 | 402.85 | 953.38 | 44.02 |
| Change | -0.52 | -11.30 | +1.77 | -3.62 | +0.03 |
| % Change | -0.49% | -3.63% | +0.44% | -0.38% | +0.07% |
| Volume | 298,917 | 2,310,401 | 434,602 | 110,739 | 3,717,163 |
| 20-Day Average Volume | 717,349 | 2,666,442 | 1,005,344 | 507,279 | 14,027,396 |
| Previous Close | 107.19 | 311.29 | 401.08 | 957.00 | 43.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 92.80 | 273.73 | 398.32 | 910.61 | 47.11 |
| 20-Day Raw Stochastic | 81.69% | 60.98% | 66.16% | 89.87% | 8.05% |
| 20-Day Relative Strength | 65.93% | 61.98% | 47.93% | 57.84% | 29.35% |
| Weighted Alpha | +112.43 | +27.01 | +14.70 | +27.68 | -36.17 |
| Today's Opinion | 100% Buy | 24% Buy | 8% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 100% Buy | 24% Buy | 8% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 100% Buy | 8% Sell | 40% Buy | 56% Buy | 16% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +13.92% since 04/29/24 | +7.98% since 04/29/24 | +1.46% since 04/29/24 | +6.81% since 04/29/24 | -1.42% since 04/29/24 |
| Low | 90.75 on 04/30/24 | 272.35 on 04/30/24 | 391.70 on 04/30/24 | 885.01 on 04/30/24 | 43.33 on 05/02/24 |
| High | 110.93 on 05/03/24 | 322.60 on 05/03/24 | 407.59 on 05/06/24 | 962.10 on 05/06/24 | 44.76 on 04/30/24 |
| 1-Month | |||||
| %Chg | +15.72% since 04/05/24 | +10.55% since 04/05/24 | -1.15% since 04/05/24 | +1.12% since 04/05/24 | -14.25% since 04/05/24 |
| Low | 84.33 on 04/15/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 110.93 on 05/03/24 | 322.60 on 05/03/24 | 407.59 on 05/06/24 | 962.10 on 05/06/24 | 51.68 on 04/09/24 |
| 3-Month | |||||
| %Chg | +37.44% since 02/06/24 | -5.58% since 02/06/24 | -3.40% since 02/06/24 | +1.65% since 02/06/24 | -10.67% since 02/06/24 |
| Low | 72.24 on 02/14/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 110.93 on 05/03/24 | 322.60 on 05/03/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +80.59% since 11/06/23 | +9.39% since 11/06/23 | +4.20% since 11/06/23 | +14.52% since 11/06/23 | -16.64% since 11/06/23 |
| Low | 56.74 on 11/13/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.33 on 05/02/24 |
| High | 110.93 on 05/03/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,560,028 | 166,968,480 | 103,662,736 | 105,042,232 | 89,172,128 |
| Shares Outstanding, K | 61,200 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 249,380,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -506,980,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 71,960,000 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | -110,920,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 0.65 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.40 on 05/02/24 | 3.96 on 05/02/24 | 4.20 on 02/05/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.94 | 29.77 | 25.27 | 41.62 |